Stockscreener 앱 받기
32.53
5.96%
-2.06
시간 외 거래:
32.53
Anbio Biotechnology 주식(NNNN)의 최신 뉴스
Anbio Biotechnology falls -5.8% - MSN
Anbio Biotechnology (NASDAQ:NNNN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - simplywall.st
Anbio Biotechnology's (NASDAQ:NNNN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Yahoo Finance
Anbio Biotechnology Posts Higher Margins and Profits Despite Revenue Dip in First Half of 2025 - The Globe and Mail
Anbio Biotechnology | 6-K: Report of foreign private issuer (related to financial reporting) - 富途牛牛
Anbio Biotechnology Reports Earnings Results for the Half Year Ended June 30, 2025 - marketscreener.com
Why Anbio Biotechnology Class A Shares Are Sliding - TipRanks
Why Anbio Biotechnology Class A Shares Keep Sliding - TipRanks
Year-End Review | The 2025 US IPO Gainers List is Out! Anbio Biotechnology Soars Over 570%, 'First Stablecoin Stock' Circle Surges More Than 180% - 富途牛牛
Anbio Biotechnology rises 11.2% - MSN
Why Anbio Biotechnology Class A Shares Are Rising - TipRanks
Top US Stock Losers Today (December 10, 2025): Why Polestar, AeroVironment, Aegon and Other Names Are Sinking - ts2.tech
Morning Market Movers: PLRZ, PMI, CBIO, HY See Big Swings - RTTNews
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Anbio Biotechnology (NNNN) Stock Analysis Report | Financials & Insights - Benzinga
Anbio Biotechnology plummets 56% after InvestingPro’s overvalued warning By Investing.com - Investing.com Nigeria
Anbio Biotechnology trading resumes - MSN
Working capital per share of Anbio Biotechnology Class A – DUS:N3B - TradingView
Anbio Biotechnology rises 15.4% - MSN
Anbio Biotechnology Shares Surge Amid Auditor Appointment - TipRanks
Anbio BiotechnologyClass A Ordinary Shares (Nasdaq:NNNN) Stock Quote | Star Tribune - FinancialContent
Anbio Biotechnology Appoints New Auditor - TipRanks
Anbio Biotechnology (NNNN) Stock Analysis: Navigating Volatility In The Healthcare Sector - DirectorsTalk Interviews
[6-K] Anbio Biotechnology Current Report (Foreign Issuer) | NNNN SEC FilingForm 6-K - Stock Titan
Anbio Biotechnology (N3B.F) latest press releases and corporate news - Yahoo Finance UK
Anbio Biotechnology trading halted, volatility trading pause - MSN
Medtech test developer Anbio files for $9M US IPO - MSN
Why Anbio Biotechnology Class A Stocks Are Tumbling - TipRanks
Anbio Biotechnology Shares on a Wild Ride - TipRanks
Anbio Biotechnology falls -19.5% - MSN
Why Anbio Biotechnology Stock is Tumbling - TipRanks
Anbio Biotechnology (NNNN) Stock Forecast & Price Targets: Today, Tomorrow, Next Week - Traders Union
Anbio Biotechnology (NNNN) Stock Price Today | Live Chart & News - Traders Union
Anbio Biotechnology (NNNN) Stock Price Prediction for 2025, 2026, 2030-2040 - Traders Union
Anbio Biotechnology falls -5.5% - MSN
Anbio Biotechnology falls -26.6% - MSN
Why Anbio Biotechnology’s Stock is Tumbling - TipRanks
Anbio Biotechnology Class A Ordinary Shares 7-Year Stock Forecast ( 2031 2032 - Meyka
Anbio Biotechnology (N3B.F) Stock Price, News, Quote & History - Yahoo
Anbio Biotechnology’s Hype And Hard Approvals Suggest A Stretched Valuation (NNNN) - Seeking Alpha
Anbio Biotechnology (N3B.F) Latest Press Releases & Corporate News - Yahoo
Page 795 - Laotian Times
Anbio Biotechnology prices $8M IPO at $5 per share - MSN
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025 - digitalmore.co
Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400% - inkl
Anbio Biotechnology rises 40.5% - MSN
Anbio Biotechnology Class A Shares Take a Tumble - TipRanks
0.01%
1.19%
자본화:
|
볼륨(24시간):